NeuroOne Medical Technologies Corpo... (NMTC)

$1.55

-0.20 (-11.43%)
Rating:
Recommendation:
-
Symbol NMTC
Price $1.55
Beta 0.497
Volume Avg. 0.25M
Market Cap 25.124M
Shares () -
52 Week Range 0.51-3.18
1y Target Est -
DCF Unlevered NMTC DCF ->
DCF Levered NMTC LDCF ->
ROE -97.47% Strong Sell
ROA -97.39% Strong Sell
Operating Margin -
Debt / Equity 8.97% Neutral
P/E -1.88 Sell
P/B 2.36 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NMTC news


Mr. David A. Rosa
Healthcare
Medical Devices
NASDAQ Capital Market

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.